首页|期刊导航|广州中医药大学学报|补体、NPAR与特发性膜性肾病及脾肾阳虚证的相关性研究

补体、NPAR与特发性膜性肾病及脾肾阳虚证的相关性研究OA

Study on the Correlation Between Complement,NPAR and Idiopathic Membranous Nephropathy and Spleen-Kidney Yang Deficiency Syndrome

中文摘要英文摘要

[目的]探讨补体、中性粒细胞百分比与白蛋白比率(NPAR)与特发性膜性肾病(IMN)脾肾阳虚证及肾脏病理、生化指标的相关性.[方法]回顾性收集73例2014年1月1日至2024年6月30日于北京中医药大学东直门医院东城院区行肾穿刺诊断为IMN患者的临床资料,按肾脏组织补体C3沉积强度(免疫荧光检测结果)分为4组,分别为"-组"14例、"1+组"38例、"2+组"18例,"3+组"3例;按中医诊断标准分为脾肾阳虚证组29例和非脾肾阳虚证组44例.比较不同肾脏组织补体C3沉积强度的临床资料与病理特征;分析补体C3沉积、血清补体、NPAR与生化指标的相关性;比较脾肾阳虚证与非脾肾阳虚证组间的补体C3沉积强度、生化指标与NPAR的差异,分析NPAR对IMN脾肾阳虚证的诊断价值.[结果](1)不同肾脏组织补体C3沉积强度的生化指标和病理特征方面,4组不同肾脏组织补体C3沉积强度IMN患者的血尿酸(UA)、24 h尿蛋白定量(24hUTP)、总胆固醇(CHOL)、低密度脂蛋白胆固醇(LDL-C)、总蛋白、白蛋白、NPAR比较,差异均有统计学意义(P<0.05或P<0.01);4组不同肾脏组织补体C3沉积强度IMN患者的肾间质纤维化和肾小管萎缩比较,差异也均有统计学意义(P<0.05).(2)相关性分析发现,IMN肾脏组织补体C3沉积与NPAR、24hUTP、CHOL、LDL-C呈正相关(r=0.334、0.268、0.375、0.451,P<0.05),与UA、总蛋白、白蛋白呈负相关(r=-0.275、-0.375、-0.388,P<0.05);血清补体C3与甘油三酯(TG)呈正相关(r=0.266,P<0.05),与高密度脂蛋白胆固醇(HDL-C)呈负相关(r=-0.255,P<0.05);血清补体C4与NPAR、24hUTP、TG、LDL-C呈正相关(r=0.240、0.257、0.403、0.254,P<0.05);NPAR与24hUTP、CHOL、LDL-C呈正相关(r=0.538、0.577、0.603,P<0.05),与UA、总蛋白、白蛋白呈负相关(r=-0.265、-0.797、-0.887,P<0.05).(3)脾肾阳虚证组与非脾肾阳虚证组的肾脏组织补体C3沉积强度、NPAR及临床参数方面,脾肾阳虚证组的肾脏组织补体C3沉积强度、NPAR、24hUTP、CHOL、LDL-C水平高于非脾肾阳虚证组,总蛋白、白蛋白水平低于非脾肾阳虚证组,差异均有统计学意义(P<0.05或P<0.01).(4)NPAR对IMN脾肾阳虚证的诊断价值方面,受试者工作特征(ROC)曲线分析发现,NPAR诊断IMN脾肾阳虚证的曲线下面积(AUC)为0.705(95%CI:0.586~0.824),截断值为25.18,差异有统计学意义(P<0.05).[结论]肾脏组织补体C3的广泛沉积、高血清补体C4水平、高NPAR值均与肾活检时IMN更重的病情状况相关,其水平可为临床病情判断提供参考;IMN脾肾阳虚证患者病情更重且与肾脏组织补体C3沉积强度相关;NPAR对脾肾阳虚证有一定诊断价值,有望成为IMN的风险预测指标和炎性标志物.

Objective To explore the correlation between complement,neutrophil percentage-to-albumin ratio(NPAR)and spleen-kidney yang deficiency syndrome,renal pathology and biochemical indexes in idiopathic membranous nephropathy(IMN).Methods Clinical data of 73 IMN patients diagnosed by renal biopsy at Dongcheng Campus of Dongzhimen Hospital,Beijing University of Chinese Medicine from January 1,2014 to June 30,2024 were retrospectively collected.According to the deposition intensity of complement C3 in renal tissue(immunofluorescence results),the patients were divided into four groups:"-group"(14 cases),"1+group"(38 cases),"2+group"(18 cases)and"3+group"(3 cases).According to TCM diagnostic criteria,they were divided into spleen-kidney yang deficiency syndrome group(29 cases)and non-spleen-kidney yang deficiency syndrome group(44 cases).The clinical data and pathological characteristics of different renal complement C3 deposition intensities were compared.The correlations between complement C3 deposition,serum complement,NPAR and biochemical indexes were analyzed.The differences in renal complement C3 deposition intensity,biochemical indexes and NPAR between spleen-kidney yang deficiency syndrome group and non-spleen-kidney yang deficiency syndrome group were compared,and the diagnostic value of NPAR for spleen-kidney yang deficiency syndrome in IMN was analyzed.Results(1)In terms of biochemical indexes and pathological characteristics with different renal complement C3 deposition intensities:there were statistically significant differences in serum uric acid(UA),24hUTP,total cholesterol(CHOL),low-density lipoprotein cholesterol(LDL-C),total protein,albumin and NPAR among the four groups of IMN patients with different renal complement C3 deposition intensities,the difference being statistically significant(P<0.05 or P<0.01).There were also statistically significant differences in renal interstitial fibrosis and tubular atrophy among the four groups(P<0.05).(2)Correlation analysis showed that renal complement C3 deposition in IMN was positively correlated with NPAR,24hUTP,CHOL and LDL-C(r=0.334,0.268,0.375,0.451,P<0.05),and negatively correlated with UA,total protein and albumin(r=-0.275,-0.375,-0.388,P<0.05).Serum complement C3 was positively correlated with triglyceride(TG)(r=0.266,P<0.05)and negatively correlated with high-density lipoprotein cholesterol(HDL-C)(r=-0.255,P<0.05).Serum complement C4 was positively correlated with NPAR,24hUTP,TG and LDL-C(r=0.240,0.257,0.403,0.254,P<0.05).NPAR was positively correlated with 24hUTP,CHOL and LDL-C(r=0.538,0.577,0.603,P<0.05)and negatively correlated with UA,total protein and albumin(r=-0.265,-0.797,-0.887,P<0.05).(3)In terms of renal complement C3 deposition intensity,NPAR and clinical parameters between spleen-kidney yang deficiency syndrome group and non-spleen-kidney yang deficiency syndrome group:the renal complement C3 deposition intensity,NPAR,24hUTP,CHOL and LDL-C levels in the spleen-kidney yang deficiency syndrome group were higher than those in the non-spleen-kidney yang deficiency syndrome group,while the total protein and albumin levels were lower than those in the non-spleen-kidney yang deficiency syndrome group,with statistically significant differences(P<0.05 or P<0.01).(4)In terms of the diagnostic value of NPAR for spleen-kidney yang deficiency syndrome in IMN:receiver operating characteristic(ROC)curve analysis showed that the area under the curve(AUC)of NPAR for diagnosing spleen-kidney yang deficiency syndrome in IMN was 0.705(95%CI:0.586-0.824),with a cut-off value of 25.18,and the difference was statistically significant(P<0.05).Conclusion Extensive deposition of renal complement C3,high serum complement C4 level and high NPAR value are all associated with more severe IMN at renal biopsy,and their levels can provide reference for clinical disease assessment.Patients with spleen-kidney yang deficiency syndrome of IMN have more severe disease conditions,which is correlated with renal complement C3 deposition intensity.NPAR has certain diagnostic value for spleen-kidney yang deficiency syndrome and is expected to become a risk predictor and inflammatory marker for IMN.

李丹文;吕杰;康意;郑慧娟;王耀献

北京中医药大学东直门医院,北京 100700北京中医药大学东直门医院,北京 100700北京中医药大学东直门医院,北京 100700北京中医药大学东直门医院,北京 100700北京中医药大学东直门医院,北京 100700||河南中医药大学,河南 郑州 450046

医药卫生

特发性膜性肾病脾肾阳虚证补体C3中性粒细胞百分比与白蛋白比率生化指标病理特征相关性分析

idiopathic membranous nephropathy(IMN)spleen-kidney yang deficiency syndromecomplement C3neutrophil percentage-to-albumin ratiobiochemical indexespathological characteristicscorrelation analysis

《广州中医药大学学报》 2026 (9)

2336-2343,8

国家中医药管理局高水平重点学科建设项目(编号:zyyzdxk-2023260)国家中医药管理局中医药传承与创新"百千万"人才工程项目(国中医药人教发[2018]12号,编号:RSO032)

10.13359/j.cnki.gzxbtcm.2026.09.004

评论